Fluphase 25 Injection contains Fluphenazine 25mg, a typical antipsychotic medication widely used for the long-term management of schizophrenia and other psychotic disorders. Its sustained action helps control symptoms such as hallucinations, delusions, agitation, and disorganized thinking, supporting improved patient stability and adherence.
Fluphenazine works by modulating dopaminergic activity in the brain, helping restore chemical balance associated with psychotic symptoms. The injectable formulation is especially beneficial for patients requiring long-acting therapy, ensuring consistent therapeutic levels and reducing the risk of relapse due to missed oral doses.
For hospitals, psychiatric clinics, and pharmaceutical distributors, Fluphase 25 Injection is a regularly required psychiatry-care product, commonly used in mental health institutions, inpatient psychiatric units, and long-term care facilities. Ongoing need for maintenance therapy ensures steady demand and repeat procurement.
Adding Fluphase 25 Injection to your product portfolio strengthens your psychiatry and mental-health segment, creating opportunities in hospital supply chains, institutional procurement, export markets, and third-party manufacturing. Its clinical relevance and consistent usage make it a commercially strong and strategically important product for pharmaceutical distributors.